64Cu DOTA-AE105 showed a favourable tumour-to-background ratio in both primary tumour lesions and metastatic lymph nodes in bladder cancer patients, providing strong evidence for the potential for uPAR PET-CT in bladder cancer patients [76]. This evidence concerns the gene PLAUR and urinary bladder cancer.